BAS:XETRBASF SE Analysis

BASF shares trade around €52.98, comfortably above the 20‑day SMA of €53.35 and the 50‑day SMA of €51.32, but still below the recent resistance at €54.93 and above the support at €50.67. The DCF fair value of €37.37 implies a substantial overvaluation, reflected in the -72% downside estimate, while the trailing P/E of 32.9 versus a forward P/E of 17.5 signals that earnings are expected to improve but current pricing remains stretched. Momentum indicators are mixed: the MACD histogram is negative and the signal line is bearish, yet volume is increasing and the 30‑day volatility is high at 25%, indicating active trading. The dividend yield of 4.28% looks attractive, but the payout ratio of 140% and negative free cash flow raise concerns about sustainability. With a debt‑to‑equity of 66.7% and modest ROE of 4.4%, balance‑sheet pressure is evident, while the sector’s cyclicality and regulatory environment add further headwinds. Overall, the stock appears overvalued in the near term, but the company’s diversified chemical portfolio and long‑term strategic initiatives could support a more favorable view over a longer horizon.